Emerging role of cytoreductive prostatectomy in patients with metastatic disease

about

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

Item

http://www.wikidata.org/entity/Q58562228

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

@en

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

@nl

type

Item

label

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

@en

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

@nl

prefLabel

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

@en

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

@nl

P1476

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

@en

P2093

Brian F Chapin

http://www.w3.org/2001/XMLSchema#string

Chad A Reichard

http://www.w3.org/2001/XMLSchema#string

Yasmeen Jaber

http://www.w3.org/2001/XMLSchema#string

P2860

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.

The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis.

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

The pre-metastatic niche: finding common ground.

Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment.

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer.

Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.

Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis

Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.

P304

S505-S513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2018.06.06

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

Suppl 4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30363448

http://www.w3.org/2001/XMLSchema#string

P921

urology

reproductive medicine

P932

6178312

http://www.w3.org/2001/XMLSchema#string